Format

Send to

Choose Destination
Presse Med. 2009 Jul-Aug;38(7-8):1089-98. doi: 10.1016/j.lpm.2008.11.017. Epub 2009 Feb 23.

[Wilson disease].

[Article in French]

Author information

1
Centre National de Référence pour la Maladie de Wilson, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, F-75010 Paris, France.

Abstract

Wilson Disease must be considered in very varied circumstances, including in patients older than 50 years. Its diagnosis is not based on a single test but on a group of findings. The copper levels may be difficult to interpret. Molecular biology can confirm the diagnosis in only 80% of cases. The advice of the reference center is necessary before beginning treatment: chelators or zinc salts. Lifetime treatment is required. Follow-up of these patients must be regular and multidisciplinary and should be conducted in association with the reference center. Inclusion in the national registry for Wilson Disease must be suggested to all patients.

CONTACT:

cmr.wilson@lrb.aphp.fr.

PMID:
19233606
DOI:
10.1016/j.lpm.2008.11.017
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center